Monopar Therapeutics Inc. (MNPR) Revenue History
Annual and quarterly revenue from 2015 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MNPR Revenue Growth
MNPR Revenue Analysis (2015–2024)
As of May 8, 2026, Monopar Therapeutics Inc. (MNPR) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, MNPR's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including CLDX (-78.6% YoY), TPVG, and NKTR (-43.9% YoY). Compare MNPR vs CLDX →
MNPR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MNPRCurrent | $0 | - | - | - | |
 CLDX | $2M | -78.6% | -27.4% | -19160.0% | |
 TPVG | $97M | - | - | 77.9% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 ADXN | $404,102 | -87.8% | -31.9% | -681.8% |
MNPR Historical Revenue Data (2015–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-16,161,721 | - |
| 2023 | $0 | - | $0 | - | $-8,831,235 | - |
| 2022 | $0 | - | $0 | - | $-10,536,877 | - |
| 2021 | $0 | - | $0 | - | $-9,127,248 | - |
| 2020 | $0 | - | $0 | - | $-6,508,875 | - |
| 2019 | $0 | - | $0 | - | $-4,323,761 | - |
| 2018 | $0 | - | $0 | - | $-3,403,000 | - |
| 2017 | $0 | - | $0 | - | $-16,603,000 | - |
| 2016 | $0 | - | $0 | - | $-1,192,829 | - |
| 2015 | $0 | - | $0 | - | $-689,000 | - |
See MNPR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MNPR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MNPR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMNPR — Frequently Asked Questions
Quick answers to the most common questions about buying MNPR stock.
Is MNPR's revenue growth accelerating or slowing?
MNPR TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is MNPR's long-term revenue growth rate?
Monopar Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is MNPR's revenue distributed by segment?
MNPR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2024 are available for download. Segment mix reveals concentration and diversification trends.